Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON21374Active, not recruiting
Open-label trial of sodium bicarbonate and sodium chloride in contrast-induced nephropathy (CIN) (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Incidence of contrast-induced nephropathy at 3 to 5 days and Persistent contrast-induced nephropathy or dialysis at 2 months. Started Jan 2010; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON21374.